Professional overview
Huang Xiaojun is a Chief Physician and Professor at Peking University People's Hospital, specializing in hematologic diseases and complications following hematopoietic stem cell transplantation (HSCT), including graft-versus-host disease (GVHD), infection, and relapse.
Areas of focus
Background
- 1982–1987Bachelor of Medicine, Sun Yat-sen University Medical College
- 1987–1992PhD, Beijing Medical University
- 1992–1994Attending Physician, Institute of Hematology, Peking University People's Hospital
- 1994–1998Associate Chief Physician, Institute of Hematology, Peking University People's Hospital
- 1997–1998Visiting Scholar, Albert Einstein College of Medicine Cancer Research Center
- 1998–2001Associate Professor, Institute of Hematology, Peking University People's Hospital
- 2001–2002Chief Physician, Institute of Hematology, Peking University People's Hospital
- 2002–presentProfessor and Director, Institute of Hematology, Peking University People's Hospital
Experience & recognition
- Led development of the 'Beijing Protocol' — an internationally recognized non-ex vivo T-cell-depleted haploidentical HSCT system
- The 'Beijing Protocol' is included in authoritative international textbooks including Thomas' Hematopoietic Cell Transplantation and Clinical Transplantation
- Published over 270 SCI papers as first or corresponding author, including in New England Journal of Medicine (2 letters), Journal of Clinical Oncology (3), Blood (11), and Leukemia (6)
- Led formulation of 10 clinical guidelines for hematologic diseases in China
- Recipient of the State Council Special Allowance
- Changjiang Scholar (Ministry of Education)
- National Science Fund for Distinguished Young Scholars
Professional roles
- Chair, Hematology Society, Chinese Medical Association (CMA)
- President, Asia-Pacific Society for Cell Therapy
- Chair, Executive Committee, Asia-Pacific Hematology Alliance
- Former President, Hematology Branch, Chinese Medical Doctor Association (CMDA)
- Member, International Council, American Society of Hematology (ASH)
- Editor-in-Chief, Chinese Journal of Hematology
- Deputy Editor, British Journal of Haematology
- Deputy Editor, Journal of Hematology & Oncology
Frequently asked questions
What does Dr. Huang Xiaojun specialize in?
Specializes in hematologic diseases and complications following hematopoietic stem cell transplantation (HSCT), including graft-versus-host disease (GVHD), infection, and relapse; developed the 'Beijing Protocol' — a non-ex vivo T-cell-depleted haploidentical HSCT system.
Which hospital and department is Dr. Huang Xiaojun in?
At Peking University People's Hospital, Institute of Hematology
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Huang Xiaojun has not reviewed this page.
